Skip to main content
. 2024 May 9;9(8):2372–2385. doi: 10.1016/j.ekir.2024.04.068

Table 4.

Diagnostic yield in the national KidGen cohort stratified by clinical diagnosis

Clinical diagnosis Sequencing performed number of patients Positive results number of patients Diagnostic yield percent
Alport syndrome 206 127 61.7
Tubular disease 134 74 55.2
Cystic kidney disease 506 256 50.6
Glomerular disease 50 19 38.0
Other 122 45 36.9
Complement-mediated 89 26 29.2
Nephrotic disease 142 41 28.9
CAKUT 73 18 24.7
Totala 1322 606 45.8

CAKUT, congenital anomalies of the kidney and urinary tract-syndromic; DY, diagnostic yield (was calculated using the formula: DY = (PR / [PR + NR + VUS] × 100) and is expressed in percent (%); NR, negative result; PR, positive result; VUS, a variant of unknown significance.

a

Test results were unknown for 59 patients by the end of the 2022 cut-off.